Cytokinetics Inc (CYTK)
64.33
+0.96
(+1.51%)
USD |
NASDAQ |
May 02, 13:24
Cytokinetics Free Cash Flow: -415.75M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -415.75M |
| September 30, 2023 | -443.03M |
| June 30, 2023 | -436.98M |
| March 31, 2023 | -405.79M |
| December 31, 2022 | -310.85M |
| September 30, 2022 | -271.95M |
| June 30, 2022 | -236.05M |
| March 31, 2022 | -183.00M |
| December 31, 2021 | -191.39M |
| September 30, 2021 | -83.31M |
| June 30, 2021 | -17.06M |
| March 31, 2021 | -7.078M |
| December 31, 2020 | -2.109M |
| September 30, 2020 | -68.06M |
| June 30, 2020 | -101.11M |
| March 31, 2020 | -97.54M |
| December 31, 2019 | -93.53M |
| September 30, 2019 | -85.70M |
| June 30, 2019 | -97.02M |
| March 31, 2019 | -99.20M |
| December 31, 2018 | -102.10M |
| September 30, 2018 | -114.42M |
| June 30, 2018 | -107.76M |
| March 31, 2018 | -112.37M |
| December 31, 2017 | -104.64M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.81M |
| June 30, 2017 | 10.70M |
| March 31, 2017 | 30.98M |
| December 31, 2016 | 35.39M |
| September 30, 2016 | -51.74M |
| June 30, 2016 | -49.71M |
| March 31, 2016 | -47.84M |
| December 31, 2015 | 4.321M |
| September 30, 2015 | 6.09M |
| June 30, 2015 | 6.875M |
| March 31, 2015 | 6.437M |
| December 31, 2014 | -45.95M |
| September 30, 2014 | -50.25M |
| June 30, 2014 | -30.40M |
| March 31, 2014 | -14.02M |
| December 31, 2013 | -8.26M |
| September 30, 2013 | -2.762M |
| June 30, 2013 | -21.93M |
| March 31, 2013 | -37.21M |
| December 31, 2012 | -33.56M |
| September 30, 2012 | -37.35M |
| June 30, 2012 | -37.79M |
| March 31, 2012 | -41.73M |
| December 31, 2011 | -46.04M |
| September 30, 2011 | -44.25M |
Free Cash Flow Range, Past 5 Years
-443.03M
Minimum
Sep 2023
-2.109M
Maximum
Dec 2020
-186.70M
Average
-101.11M
Median
Jun 2020
Free Cash Flow Benchmarks
| Amgen Inc | 7.359B |
| Johnson & Johnson | 18.23B |
| Eli Lilly and Co | -3.896B |
| Viking Therapeutics Inc | -54.87M |
| Madrigal Pharmaceuticals Inc | -325.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -74.04M |
| Cash from Investing (Quarterly) | -81.41M |
| Cash from Financing (Quarterly) | 168.80M |
| Free Cash Flow Per Share (Quarterly) | -0.7479 |
| Free Cash Flow to Equity (Quarterly) | -82.55M |
| Free Cash Flow Yield | -6.70% |